Clinical Research
Now Enrolling
The Iowa Clinic is currently participating in a number of clinical trials. The following are opportunities to participate in studies with investigational medications awaiting FDA approval. Participants will be closely monitored and will receive study medication and study related activities at no cost.
BPH
An Adaptive, Phase 2b/3, Double-blind, Randomized, Placebo-controlled Study to Establish the Dosage, Efficacy, and Safety of L-O-M® MCS in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Treatment-naïve Male Subjects. NOW ENROLLING
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Multicenter Safety and Efficacy Study of a Single Transrectal Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms NOW ENROLLING
Celiac Disease
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease NOW ENROLLING
Diabetes
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment In CoMbination with OrAl Anti-HyperGlycemia MedIcations in INsulin NaïvE Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
The IMAGINE 2 Study NOW ENROLLING
Nocturia
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of SER120 Nasal Spray Formulations in Patients with Nocturia NOW ENROLLING
Prostate Cancer
A Randomized, Double-Blind, Parallel, Placebo-Controlled, Phase 4, Multi-center Study to Assess Efficacy and Safety of VESIcare® (Solifenacin Succinate) to Improve Urinary Continence of Subjects after Robotic Assisted Radical Prostatectomy NOW ENROLLING
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer NOW ENROLLING
A Randomized, Double-Blind, Phase 3 Efficacy Trial of PROSTVAC + GM-CSF in Men with Asymptomatic or Minimally Symptomatic, Castrate-Resistant Adenocarcinoma of the Prostate NOW ENROLLING
A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects with Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss due to Androgen-Deprivation Therapy. NOW ENROLLING
CLOSED STUDIES
Interstitial Cystitis/Painful Bladder Syndrome
A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study Evaluating the Efficacy and Safety of Tanezumab for the Treatment of Moderate to Severe Pain Associated with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). CLOSED
Prostate Cancer
A Multi-Center Clinical Study of the Sonoblate 500 (SB-500) for the Treatment of locally (T1c/T2a) Recurrent Prostate Cancer with HIFU. CLOSED
If you would like more information, including basic eligibility criteria and study site location regarding the above-mentioned studies, please call The Iowa Clinic Research office at 515-875-9815 or e-mail mlepic@iowaclinic.com
